Dr. Matt Kalaycio - CML - Chronic myeloid leukemia
"Dr. Matt E. Kalaycio is an oncologist in Cleveland, Ohio and is affiliated with Cleveland Clinic. He received his medical degree from West Virginia University School of Medicine and has been in practice for more than 20 years."
Extract of US News Health
ARTICLES
Matt Kalaycio, MD, Discusses the Historical Treatment of CML
February 24, 2020, Oncology Learning Network
Updates and Controversies in CML With Matt Kalaycio
December 6, 2019, Outspoken Oncology
No Excess Risk of Second Malignancies in Chronic Myeloid Leukemia (CML) Patients Treated with Tyrosine Kinase Inhibitors (TKIs)
December 7, 2017, Journal Blood
Matt Kalaycio, MD, Discusses the Historical Treatment of CML
February 24, 2020, Oncology Learning Network
Updates and Controversies in CML With Matt Kalaycio
December 6, 2019, Outspoken Oncology
No Excess Risk of Second Malignancies in Chronic Myeloid Leukemia (CML) Patients Treated with Tyrosine Kinase Inhibitors (TKIs)
December 7, 2017, Journal Blood